Business
SERA PROGNOSTICS AND NEWBORN FOUNDATION PARTNER TO REDUCE RISKS ASSOCIATED WITH PRETERM BIRTH AND IMPROVE HEALTH EQUITY THROUGH THE "EVERY MOTHER, EVERY BABY" PROJECT
Project focused on reducing maternal and neonatal mortality and morbidity by mitigating risks associated with unanticipated preterm birth SALT LAKE CITY, May
About this update from Sera Prognostics, Inc.
[{"type":"text","content":"Project focused on reducing maternal and neonatal mortality and morbidity by mitigating risks associated with unanticipated preterm birth \nSALT LAKE CITY, May 5, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, and the Newborn Foundation today announced the launch of the Every Mother, Every Baby Project.\n\n \n \n \n \n \n \n\n \nThe Every Mother, Every Baby Project, developed by the Newborn Foundation in partnership with Sera, is designed to educate clinical practitioners, policymakers, and public health stakeholders about the critical role that validated biomarker-based preterm risk assessment tests like Sera's PreTRM® test can play in improving neonatal and maternal health outcomes. The Newborn Foundation will work collaboratively with industry and public health stakeholders to advance the educational, policy and implementation framework around earlier recognition of risks associated with preterm birth as a means to improve health equity and achieve commitments to the United Nations' Sustainable Development Goals.\nThe announcement comes on the heels of a 2-day forum in which the Newborn Foundation convened maternal and newborn health stakeholders to define 2022 domestic and global health policy priorities.\n\"Neonatal mortality is the leading cause of preventable child death globally. More than 60% of infant deaths occur during the neonatal period, and 35% of all deaths among newborns are caused by being born too soon,\" said Annamarie Saarinen, CEO of the Newborn Foundation. \"Biomarker tests that identify women at risk of preterm birth and enable risk-reduction interventions are essential for reducing neonatal mortality and improving outcomes. The Every Mother, Every Baby Project will help answer the key questions needed to ensure broad and affordable access to these tests regardless of a pregnant woman's geographic or socioeconomic status. We are pleased to partner with Sera and other global health stakeholders to achieve this important goal.\"\nThe Every Mother, Every Baby Project is designed to achieve three key objectives:\nReduce maternal and newborn mortality through mitigation of risks associated with unanticipated preterm birth.Deploy an effective, eff...